Dosage and administration
As a dietary supplement for pregnant and nursing women. Take one softgel and one tablet daily with a meal. For adults only. Consult your doctor before taking any supplement.
As a dietary supplement for pregnant and nursing women. Take one softgel and one tablet daily with a meal. For adults only. Consult your doctor before taking any supplement.
vitaMedMD™ Plus Rx is a prescription prenatal/postnatal dietary supplement containing a solid white multivitamin tablet and a red opaque softgel.
Serving Size: 1 Tablet
| MULTIVITAMIN/MULTIMINERAL | Amount per Tablet | % Daily Value Pregnant and Nursing Women |
|---|---|---|
| Vitamin C (as ascorbic acid) | 60 mg | 100% |
| Vitamin D3 (as cholecalciferol) | 600 IU | 150% |
| Vitamin E (as dl-alpha tocopheryl acetate) | 30 IU | 100% |
| Vitamin B1 (as thiamine mononitrate) | 3 mg | 176% |
| Vitamin B2 (as riboflavin 5 phosphate sodium) | 3.4 mg | 170% |
| Vitamin B3 (as niacinamide) | 20 mg | 100% |
| Vitamin B6 (as pyridoxine HCl) | 25 mg | 1000% |
| Folate | 1 mg | 125% |
| Quatrefolic®((6S)-5-methyltetrahydrofolic acid, glucosamine salt) 600 mcg Folic acid 400 mcg | ||
| Vitamin B12 (as cyanocobalamin) | 12 mcg | 150% |
| Biotin (as d-Biotin) | 300 mcg | 100% |
| Pantothenic Acid (as d-calcium pantothenate) | 10 mg | 100% |
| Calcium (as calcium carbonate) | 150 mg | 12% |
| Iron (as iron amino acid chelate) | 30 mg | 167% |
| Iodine (as potassium iodide) | 150 mcg | 100% |
| Zinc (as zinc amino acid chelate) | 15 mg | 100% |
| Copper (as copper amino acid chelate) | 2 mg | 100% |
Microcrystalline cellulose, stearic acid, croscarmellose sodium, magnesium stearate, silicon dioxide, titanium dioxide, hypromellose, inulin, medium chained triglycerides and natural orange flavor.
Gelatin capsule (porcine gelatin, glycerin, purified water, carmine, annatto, caramel, titanium dioxide), high oleic sunflower oil, sunflower lecithin, rosemary extract, tocopherols and ascorbyl palmitate as antioxidants.
vitaMedMD™ Plus Rx is a dietary supplement with DHA indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and non-lactating mothers. vitaMedMD™ Plus Rx can also be beneficial in improving the nutritional status of women prior to conception.
This product is contraindicated in patients with known hypersensitivity to any of the ingredients.
| WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately. |
Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient. Folic acid in doses above 0.1 mg daily may obscure pernicious anemia, in that hematologic remission can occur while neurological manifestations remain progressive.
Ingestion of more than 3 grams of omega-3 fatty acids (such as DHA) per day has been shown to have potential antithrombotic effects, including an increased bleeding time and INR. Administration of omega-3 fatty acids should be avoided in patients on anticoagulants and in those known to have an inherited or acquired predisposition to bleeding.
Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
As a dietary supplement for pregnant and nursing women. Take one softgel and one tablet daily with a meal. For adults only. Consult your doctor before taking any supplement.
Unit dose box of 30 softgels + 30 tablets
Product Code 10782-201-60
KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN.
Marketed and Distributed by: TherapeuticsMD™
951 Broken Sound Parkway NW, #320, Boca Raton, Florida 33487
800.728.0009
www.TherapeuticsMD.com
Quatrefolic® is a registered trademark of Gnosis Spa.
U.S. Patent No. 7,947,662; and other patents pending.
PLRX-0008 01/12
Product Code 10782-201-60
vitaMedMD™
Plus Rx WITH Quatrefolic®
Prenatal Multivitamin
Plus DHA Softgel
MULTIVITAMIN TABLET
16 Vitamins and Minerals
DHA SOFTGEL
300 mg of Plant-based life'sDHA™
DOCTOR-RECOMMENDED
for women planning a pregnancy,
pregnant or nursing
TherapeuticsMD™
30 TABLETS + 30 SOFTGELS
DIETARY SUPPLEMENT

| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 10782-201-60 | EA - Each | 10782-201 | 5ed5d190-188f-47cd-8881-fb14a55958b5 | 1 | 2013-02-19 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| .alpha.-tocopherol acetate, dl- | ACTIVE INGREDIENT | WR1WPI7EW8 | 2 | |
| 5-methyltetrahydrofolic acid | ACTIVE INGREDIENT | TYK22LML8F | 2 | |
| ascorbic acid | ACTIVE INGREDIENT | PQ6CK8PD0R | 2 | |
| biotin | ACTIVE INGREDIENT | 6SO6U10H04 | 2 | |
| calcium carbonate | ACTIVE INGREDIENT | H0G9379FGK | 2 | |
| calcium pantothenate | ACTIVE INGREDIENT | 568ET80C3D | 2 | |
| cholecalciferol | ACTIVE INGREDIENT | 1C6V77QF41 | 2 | |
| copper | ACTIVE INGREDIENT | 789U1901C5 | 2 | |
| cyanocobalamin | ACTIVE INGREDIENT | P6YC3EG204 | 2 | |
| doconexent | ACTIVE INGREDIENT | ZAD9OKH9JC | 2 | |
| ferrous bisglycinate hydrochloride | ACTIVE INGREDIENT | IW3QLZ8MRC | 2 | |
| folic acid | ACTIVE INGREDIENT | 935E97BOY8 | 2 | |
| niacinamide | ACTIVE INGREDIENT | 25X51I8RD4 | 2 | |
| potassium iodide | ACTIVE INGREDIENT | 1C4QK22F9J | 2 | |
| pyridoxine hydrochloride | ACTIVE INGREDIENT | 68Y4CF58BV | 2 | |
| riboflavin | ACTIVE INGREDIENT | TLM2976OFR | 2 | |
| thiamine mononitrate | ACTIVE INGREDIENT | 8K0I04919X | 2 | |
| zinc glycinate | ACTIVE INGREDIENT | 681VJX72FE | 2 | |
| .alpha.-tocopherol, dl- | ACTIVE MOIETY | 7QWA1RIO01 | 2 | |
| 5-methyltetrahydrofolic acid | ACTIVE MOIETY | TYK22LML8F | 2 | |
| ascorbic acid | ACTIVE MOIETY | PQ6CK8PD0R | 2 | |
| biotin | ACTIVE MOIETY | 6SO6U10H04 | 2 | |
| calcium cation | ACTIVE MOIETY | 2M83C4R6ZB | 2 | |
| cholecalciferol | ACTIVE MOIETY | 1C6V77QF41 | 2 | |
| copper | ACTIVE MOIETY | 789U1901C5 | 2 | |
| cyanocobalamin | ACTIVE MOIETY | P6YC3EG204 | 2 | |
| doconexent | ACTIVE MOIETY | ZAD9OKH9JC | 2 | |
| ferrous cation | ACTIVE MOIETY | GW89581OWR | 2 | |
| folic acid | ACTIVE MOIETY | 935E97BOY8 | 2 | |
| iodide ion | ACTIVE MOIETY | 09G4I6V86Q | 2 | |
| niacinamide | ACTIVE MOIETY | 25X51I8RD4 | 2 | |
| pantothenic acid | ACTIVE MOIETY | 19F5HK2737 | 2 | |
| pyridoxine | ACTIVE MOIETY | KV2JZ1BI6Z | 2 | |
| riboflavin | ACTIVE MOIETY | TLM2976OFR | 2 | |
| thiamine ion | ACTIVE MOIETY | 4ABT0J945J | 2 | |
| zinc cation | ACTIVE MOIETY | 13S1S8SF37 | 2 | |
| annatto | INACTIVE INGREDIENT | 6PQP1V1B6O | 2 | |
| ascorbyl palmitate | INACTIVE INGREDIENT | QN83US2B0N | 2 | |
| caramel | INACTIVE INGREDIENT | T9D99G2B1R | 2 | |
| cellulose, microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | 2 | |
| croscarmellose sodium | INACTIVE INGREDIENT | M28OL1HH48 | 2 | |
| glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 2 | |
| hypromelloses | INACTIVE INGREDIENT | 3NXW29V3WO | 2 | |
| inulin | INACTIVE INGREDIENT | JOS53KRJ01 | 2 | |
| magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | 2 | |
| medium-chain triglycerides | INACTIVE INGREDIENT | C9H2L21V7U | 2 | |
| rosemary | INACTIVE INGREDIENT | IJ67X351P9 | 2 | |
| silicon dioxide | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 2 | |
| stearic acid | INACTIVE INGREDIENT | 4ELV7Z65AP | 2 | |
| sunflower oil | INACTIVE INGREDIENT | 3W1JG795YI | 2 | |
| titanium dioxide | INACTIVE INGREDIENT | 15FIX9V2JP | 2 | |
| tocopherol | INACTIVE INGREDIENT | R0ZB2556P8 | 2 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 10782-201 | 10782-201-60 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| stearic acid | STEARIC ACID | 4ELV7Z65AP | TABLET / SUBLINGUAL | 9 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / SUBCUTANEOUS | 450 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | IMPLANT / SUBCUTANEOUS | 1.04 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TAMPON / VAGINAL | NA | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | POWDER / TOPICAL | 104 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, FILM COATED / ORAL | 36 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, COATED / ORAL | 184 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | INSERT / VAGINAL | 8 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | CAPSULE, COATED PELLETS / ORAL | 3.32 mg | ||
| croscarmellose sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | PELLET / ORAL | 162 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | GEL / OPHTHALMIC | 0.88 %w/w | ||
| glycerin | GLYCERIN | PDC6A3C0OX | TABLET, COATED / ORAL | 1 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | CAPSULE / ORAL | 1488 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | JELLY / VAGINAL | NA | ||
| glycerin | GLYCERIN | PDC6A3C0OX | DROPS / NASAL | 10 mg/1ml | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, ORALLY DISINTEGRATING / ORAL | 68 mg | ||
| cellulose, microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | SUSPENSION, EXTENDED RELEASE / ORAL | 1120 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / DENTAL | 15 %w/v | ||
| croscarmellose sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | TROCHE / ORAL | 50 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | SUSPENSION / ORAL | 305 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 225 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 11 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | PELLET / SUBCUTANEOUS | 0.97 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | PASTE, DENTIFRICE / DENTAL | 18 %w/w | ||
| cellulose, microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE, EXTENDED RELEASE / ORAL | 1246 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / ORAL | 750 mg | ||
| croscarmellose sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | GRANULE, FOR SUSPENSION / ORAL | 282 mg | ||
| croscarmellose sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET, ORALLY DISINTEGRATING / ORAL | 184 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, ORALLY DISINTEGRATING / ORAL | 187 mg | ||
| caramel | CARAMEL | T9D99G2B1R | LOTION / TOPICAL | NA | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / RESPIRATORY (INHALATION) | 5 %w/w | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | DROPS / ORAL | NA | ||
| caramel | CARAMEL | T9D99G2B1R | SUSPENSION / ORAL | 111.12 mg/5ml | ||
| glycerin | GLYCERIN | PDC6A3C0OX | ELIXIR / ORAL | 5621 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAMUSCULAR | 450 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | IMPLANT / SUBCUTANEOUS | 0.5 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER / ORAL | 602 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | FILM, SOLUBLE / ORAL | 2 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | OINTMENT / TOPICAL | NA | ||
| glycerin | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / BUCCAL | 34 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | PELLET / ORAL | 24 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / TOPICAL | 1971 mg | ||
| medium-chain triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | SOLUTION / ORAL | 5566 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | POWDER / RESPIRATORY (INHALATION) | 0.13 mg | ||
| cellulose, microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, DELAYED RELEASE PARTICLES / ORAL | 580 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE, DELAYED RELEASE / ORAL | 1060 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | GEL / TOPICAL | 0.06 %w/w | ||
| glycerin | GLYCERIN | PDC6A3C0OX | CAPSULE, EXTENDED RELEASE / ORAL | 265 mg | ||
| cellulose, microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE, DELAYED RELEASE / ORAL | 366 mg | ||
| croscarmellose sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET, FOR SUSPENSION / ORAL | 1875 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION / AURICULAR (OTIC) | 0.05 %w/w | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE / RESPIRATORY (INHALATION) | NA | ||
| croscarmellose sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | CAPSULE, DELAYED RELEASE / ORAL | 72 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 221 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | TABLET / ORAL | 336 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | TABLET, CHEWABLE / ORAL | 12 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | POWDER / RESPIRATORY (INHALATION) | 2 mg | ||
| croscarmellose sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | GRANULE / ORAL | 150 mg | ||
| tocopherol | TOCOPHEROL | R0ZB2556P8 | TABLET / ORAL | 0.08 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ascorbic Acid | ASCORBIC ACID | Renova Pharmaceuticals LLC | a6481bae-2397-44c7-a51d-4f47ad91bd2c | 2026-08-19 | Warnings, Adverse reactions | ASCORBIC ACID |
| Ascor | ASCORBIC ACID | McGuff Pharmaceuticals, Inc. | 388aad52-fc01-4784-9791-1dbc80c69306 | 2026-05-29 | Warnings, Adverse reactions | ASCORBIC ACID |
| Ascorbic Acid | ASCORBIC ACID | Fresenius Kabi USA, LLC | 1606e29f-0e80-4069-b688-daab9cbff20a | 2025-12-17 | Warnings, Adverse reactions | ASCORBIC ACID |
| Skin Renewing Serum | ASCORBIC ACID | Guangzhou Danting Bath&Body Care Industry Co. Ltd | 396c2a8d-ac95-cbef-e063-6294a90aff39 | 2025-08-23 | Warnings | ASCORBIC ACID |
Adverse event summaries are temporarily unavailable. Other product information remains available.